Application of omics- and multi-omics-based techniques for natural product target discovery
2021 · Biomedicine & Pharmacotherapy · 97 citations
https://doi.org/10.1016/j.biopha.2021.111833
S
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
85
Papers
2.9K
Citations
30
h-index
54
i10-index
Sanhong Liu is an academic researcher from State Administration of Traditional Chinese Medicine of the People's Republic of China. The author has contributed to research in topics: MicroRNA in disease regulation & Cancer Immunotherapy and Biomarkers & Cancer-related molecular mechanisms research. The author has an h-index of 30, co-authored 73 publications.
ORCID: 0000-0002-8695-0343Papers by this author
worksKDM6B-mediated histone demethylation of LDHA promotes lung metastasis of osteosarcoma
2021 · Theranostics · 81 citations
https://doi.org/10.7150/thno.53347
The Role of PIWIL4, an Argonaute Family Protein, in Breast Cancer
2016 · Journal of Biological Chemistry · 76 citations
https://doi.org/10.1074/jbc.m116.723239
The pathogenesis and potential therapeutic targets in sepsis
2023 · MedComm · 56 citations
https://doi.org/10.1002/mco2.418
Benzosceptrin C induces lysosomal degradation of PD-L1 and promotes antitumor immunity by targeting DHHC3
2024 · Cell Reports Medicine · 56 citations
https://doi.org/10.1016/j.xcrm.2023.101357
Lyophilized powder of mesenchymal stem cell supernatant attenuates acute lung injury through the IL-6–p-STAT3–p63–JAG2 pathway
2021 · Stem Cell Research & Therapy · 44 citations
https://doi.org/10.1186/s13287-021-02276-y
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat